Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.
2.
3.

[Fluoxetine in the treatment of borderline personality disorder].

Silva H, Jerez S, Paredes A, Salvo J, Rentería P, Ramírez A, Montes C.

Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1997 Nov-Dec;25(6):391-5. Spanish.

PMID:
9477607
4.

Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.

Bellino S, Paradiso E, Bogetto F.

J Clin Psychiatry. 2006 Jul;67(7):1042-6.

PMID:
16889446
5.

Adaptive functioning and psychiatric symptoms in adolescents with borderline personality disorder.

Chanen AM, Jovev M, Jackson HJ.

J Clin Psychiatry. 2007 Feb;68(2):297-306.

PMID:
17335330
6.

Quetiapine in patients with borderline personality disorder: an open-label trial.

Adityanjee, Romine A, Brown E, Thuras P, Lee S, Schulz SC.

Ann Clin Psychiatry. 2008 Oct-Dec;20(4):219-26. doi: 10.1080/10401230802467545.

PMID:
19034754
7.

[Symptoms of DSM IV borderline personality disorder in a nonclinical population of adolescents: study of a series of 35 patients].

Chabrol H, Chouicha K, Montovany A, Callahan S.

Encephale. 2001 Mar-Apr;27(2):120-7. French.

PMID:
11407263
8.

A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.

Hollander E, Allen A, Lopez RP, Bienstock CA, Grossman R, Siever LJ, Merkatz L, Stein DJ.

J Clin Psychiatry. 2001 Mar;62(3):199-203.

PMID:
11305707
9.

The psychopharmacology of borderline personality disorders.

Montgomery SA.

Acta Psychiatr Belg. 1987 May-Jun;87(3):260-6.

PMID:
3673629
10.

Two weeks' quetiapine treatment for schizophrenia, drug-induced psychosis and borderline personality disorder: a naturalistic study with drug plasma levels.

Mauri MC, Volonteri LS, Fiorentini A, Pirola R, Bareggi SR.

Expert Opin Pharmacother. 2007 Oct;8(14):2207-13.

PMID:
17927477
11.

Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial.

Bohus MJ, Landwehrmeyer GB, Stiglmayr CE, Limberger MF, Böhme R, Schmahl CG.

J Clin Psychiatry. 1999 Sep;60(9):598-603.

PMID:
10520978
12.

Efficacy of phenelzine and haloperidol in borderline personality disorder.

Soloff PH, Cornelius J, George A, Nathan S, Perel JM, Ulrich RF.

Arch Gen Psychiatry. 1993 May;50(5):377-85.

PMID:
8489326
13.

An open-label trial of divalproex extended-release in the treatment of borderline personality disorder.

Simeon D, Baker B, Chaplin W, Braun A, Hollander E.

CNS Spectr. 2007 Jun;12(6):439-43.

PMID:
17545954
14.

Treatment of borderline personality disorder with risperidone.

Rocca P, Marchiaro L, Cocuzza E, Bogetto F.

J Clin Psychiatry. 2002 Mar;63(3):241-4.

PMID:
11926724
15.

Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial.

Golubchik P, Sever J, Zalsman G, Weizman A.

Int Clin Psychopharmacol. 2008 Jul;23(4):228-31. doi: 10.1097/YIC.0b013e3282f94ae2.

PMID:
18446088
16.

Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder.

Benedetti F, Sforzini L, Colombo C, Maffei C, Smeraldi E.

J Clin Psychiatry. 1998 Mar;59(3):103-7.

PMID:
9541151
17.

Risperidone treatment of borderline personality disorder assessed by a borderline personality disorder-specific outcome measure: a pilot study.

Friedel RO, Jackson WT, Huston CS, May RS, Kirby NL, Stoves A.

J Clin Psychopharmacol. 2008 Jun;28(3):345-7. doi: 10.1097/JCP.0b013e318173083e. No abstract available.

PMID:
18480695
18.

Better than expected: improvements in borderline personality disorder in a 3-year prospective outcome study.

Najavits LM, Gunderson JG.

Compr Psychiatry. 1995 Jul-Aug;36(4):296-302.

PMID:
7554874
19.

Borderline personality disorder features and utilization of treatment over two years.

Bagge CL, Stepp SD, Trull TJ.

J Pers Disord. 2005 Aug;19(4):420-39.

PMID:
16178683
20.

Pharmacotherapy of the borderline patient.

Jerome L.

Can J Psychiatry. 1990 Aug;35(6):572. No abstract available.

PMID:
1976431

Supplemental Content

Support Center